Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis

Human Reproduction

Volumn 18, Issue 7, 2003, Pages 1516-1522

  Gilabert Estelles J ^a   Estellés, Amp ^a   Gilabert, J ^b   Castello R ^a   Espana F ^a   Falco C ^a   Romeu, A ^a   Chirivella, M ^a   Zorio, E ^a   Aznar, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Endometriosis; MMP 3; PAIs; Plasminogen activators; TIMP 1

Indexed keywords

MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CYST; PERITONEAL FLUID; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 10744227350     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg300     Document Type: Article

References (52)

1. American Fertility Society. (1985) Revised American Fertility Society classification of endometriosis. Fertil. Steril., 43, 351.
2. Andreasen, P.A., Kjoller, L., Christensen, L. and Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: A review. Int. J. Cancer., 72, 1-22.
3. Astedt, B. and Nordenskjold, F. (1984) Plasminogen activators in endometriosis. Acta Obstet. Gynecol. Scand., Suppl., 123, 23-24.
4. Batzofin, J.H., Holmes, S.D., Gibbons, W.E. and Buttram, V.C., Jr (1985) Peritoneal fluid plasminogen activator activity in endometriosis and pelvic adhesive disease. Fertil. Steril., 44, 277-279.
5. Bouchet-Bernet, C., Spyratos, F., Andrieu, C., Deytieux, S., Becette, V. and Oglobine, J. (1996) Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues. Breast Cancer Res. Treat., 41, 141-146.
6. Bouckaert, P.X., Evers, J.L., Doesburg, W.H., Schellekens, L.A. and Rolland, R. (1986) Patterns of changes in glycoproteins, polypeptides, and steroids in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle. J. Clin. Endocrinol. Metab., 62, 293-299.
7. Brand, K. (2002) Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr. Gene Ther., 2, 255-271.
8. Bruner-Tran, K.L., Eisenberg, E., Yeaman, G.R., Anderson, T.A., McBean, J and Osteen, K.G. (2000) Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J. Clin. Endocrinol. Metab., 87, 4782-4791.
9. Bruse, C., Bergqvist, A., Carlstrom, K., Fianu-Jonasson, A., Lecander, I. and Astedt, B. (1998) Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil. Steril., 70, 821-826.
10. Castelló R, Estellés, A., Vázquez, C., Falcó, C, España, F., Almenar, S.M., Fuster, C. and Aznar, J. (2002) Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 (PAI-1) and tissue metalloproteinase inhibitor type 1 (TIMP-1) gene expression in primary breast cancer. Clin. Chem., 48, 1288-1295.
11. Chung, H.W., Wen, Y., Chun, S.H., Nezhat, C., Woo, B.H. and Polan, M.L. (2001) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil. Steril., 75, 152-159.
12. Chung, H.W., Lee, J.Y., Moon, H.-S., Hur, S.E., Park, M.H., Wen, Y. and Polan, M.L. (2002) Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil. Steril., 78, 787-795.
13. Cox, K.E., Piva, M. and Sharpe-Timms, K.L. (2001) Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol. Reprod., 65, 1297-1303
14. Edelstam, G., Lecander, I., Larsson, B. and Astedt, B. (1998) Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease. Inflammation, 22, 341-351.
15. España, F and Griffin, J.H. (1989) Determination of functional and antigen protein C inhibitor and its complexes with activated protein C in plasma by ELISAs. Thromb. Res., 55, 671-682.
16. España, F., Gilabert, J., Estelles, A., Romeo, A., Aznar, J. and Cabo, A. (1991) Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb. Res., 64, 309-320.
17. España, F., Estellés, A., Fernández, P.J., Gilabert, J., Sánchez-Cuenca, J. and Griffin, J.H. (1993) Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb. Haemostasis, 70, 989-994.
18. España, F., SanchezCuenca, J., Fernández, P.J., Gilabert, J., Romeu, A., Estellés, A., Royo, M. and Muller, C.H. (1999) Inhibition of human sperm-zona-free hamster oocyte binding and penetration by protein C inhibitor. Andrologia, 31, 217-223.
19. Estellés, A., Gilabert, J., Keeton, M., Eguchi, Y., Aznar, J., Grancha, S., España, F., Loskutoff, D.J. and Schleef, R.R. (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood, 84, 143-150.
20. Fernandez-Shaw, S., Marshall, J.M., Hicks, B., Barlow, D.H. and Starkey, P.M. (1995) Plasminogen activators in ectopic and uterine endometrium. Fertil. Steril., 63, 45-51.
21. Gilabert, J., Estellés, A., Cano, A., España, F., Barachina, R., Grancha, S., Aznar, J. and Tortajada, M. (1995a) The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. Am. J. Obstet. Gynecol., 173, 1849-1854.
22. Gilabert, J., Estellés, A., Grancha, S., España, F. and Aznar, J. (1995b) Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in preeclampsia. Hum. Reprod., 10, 121-131.
23. Giudice, L.C., Tazude, S.I. and Swiersz, L. (1998) Status of current research on endometriosis. J. Reprod. Med., 43 Suppl. 3, 252-262.
24. Gogusev, J., Bouquet De Joliniere, J., Telvi, L., Doussau, M., Du Manoir, S., Stojkoski, A. and Levardon, M. (2000) Genetic abnormalities detected by comparative genomic hybridization in a human endometriosis-derived cell line. Mol. Hum. Reprod., 6, 821-827
25. Gottschalk, C., Malberg, K., Arndt, M., Schmitt, J., Roessner, A., Schultze, D., Kleinstein, J. and Ansorge, S. (2000) Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis. Adv. Exp. Med. Biol., 477, 483-486.
26. Grancha, S., Estellés, A., Gilabert, J., Chirivella, M., España, F., Aznar, J. and Loskutoff, D.J. (1996) Decreased expression of PÄI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation. Thromb. Haemostasis, 76, 761-767.
27. Guan, Y.M., Carlberg, M., Bruse, C., Carlstrom, K. and Bergqvist, A. (2002) Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells. Acta Obstet. Gynecol. Scand., 81, 389-397.
28. Harbeck, N., Kruger, A., Sinz, S., Kates, R.E., Thomssen, C., Schmitt, M. and Janicke, F. (2001) Clinical relevance of the plasminogen activator inhibitor type 1 - A multifaceted proteolytic factor. Onkologie, 24, 238-244.
29. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. and Iwata, K. (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298, 29-32.
30. Heeb, M.J., España, F., Geiger, M., Collen, D., Stump, D.C. and Griffin, J.H. (1987) Immunological identity of heparin dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J. Biol. Chem., 262, 15813-15816.
31. Kobayashi, H. (2000) Invasive capacity of heterotopic endometrium. Gynecol. Obstet. Invest., 50 Suppl. 1, 26-32.
32. Kruithof, E.K.O., Baker, M.S. and Bunn, C.L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood, 86, 4007-4024.
33. Loskutoff, D.J. (1991) Regulation of PAI-1 gene expression. Fibrinolysis, 5, 197-206.
34. Martinez-Roman, S., Balasch, J., Creus, M., Fabregues, F., Caromona, F., Vilella, R. and Vanrell, J.A. (1997) Immunological factors in endometriosis-associated reproductive failure: Studies in fertile and infertile women with and without endometriosis. Hum. Reprod., 12, 1794-1799.
35. Matrisian, L.M., (1990) Metalloproteinases and their inhibitors in matrix remodelling. Trends. Genet., 12, 121-125.
36. Murphy, G., Knäuper, V., Atkinson, A., Gavrilovic, J. and Edwards, D. (2000) Cellular mechanisms for focal proteolysis and the regulation of the microenvironment. Fibrinolysis Proteolysis, 14, 165-174.
37. Nagase, H. and Woessner, J.F., Jr (1999) Matrix metalloproteinases. J. Biol. Chem., 274, 21491-21494.
38. Osteen, K.G., Keller, N.R., Feltus, F.A. and Melner, M.H. (1999) Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol. Obstet. Invest., 48 (Suppl. 1), 2-13.
39. Pellicer, A., Navarro, J., Bosch, E., Garrido, N., García-Velasco, J.A., Remohí, J. and Simón, C. (2001) Endometrial quality in infertile women with endometriosis. Ann. NY Acad. Sci., 943, 122-130.
40. Saito, T., Mizumoto, H., Kuroki, K., Fujii, M., Mori, S. and Kudo, R. (1995) Expression of MMP-3 and TIMP-1 in endometriosis and the influence of Danazol. Acta Obstet. Gynecol. Jap., 47, 495-496.
41. Schwartz, B.S. and España, F. (1999) Two distinct urokinase-serpin interactions regulate the initiation of cell surface-associated plasminogen activation. J. Biol. Chem., 274, 15278-15283.
42. Sharpe-Timms, K.L. (2001) Endometrial anomalies in women with endometriosis. Ann. NY Acad. Sci., 943, 131-147.
43. Sharpe-Timms, K.L., Penney, L.L., Zimmer, R.L., Wright, J.A., Zhang, Y. and Surewicz, K. (1995) Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1). J. Clin. Endocrinol. Metab., 80, 3784-3787.
44. Sharpe-Timms, K.L., Keisler, L.W., McIntush, E.W. and Keisler, D.H. (1998a) Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil. Steril., 69, 1128-1134.
45. Sharpe-Timms, K.L., Zimmer, R.L., Jolliff, W.J., Wright, J.A., Nothnick, W.B. and Curry, T.E. (1998b) Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: Potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil. Steril., 69, 916-923.
46. Sillem, M., Prifti, S., Monga, B., Buvari, P., Shamia, U. and Runnebaum, B. (1997) Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis. Mol. Hum. Reprod., 3, 1101-1105.
47. Sillem, M., Prifti, S., Koch, A., Neher, M., Jauckus, J. and Runnebaum, B. (2001) Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol., 95, 167-174.
48. Spuijbroek, M.D., Dunselman, G.A., Menheere, P.P. and Evers, J.L. (1992) Early endometriosis invades the extracellular matrix. Fertil. Steril., 58, 929-933.
49. Stefansson, H., Geirsson, R.T., Steinthorsdottir, V., Jonsson, H., Manolescu, A., Kong, A., Ingadottir, G., Gulcher, J. and Stefansson, K. (2002) Genetic factors contribute to the risk of developing endometriosis. Hum. Reprod., 17, 555-559.
50. Szamatowicz, J., Laudanski, P. and Tomaszewska, I. (2002) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: A possible role in the pathogenesis of endometriosis. Hum. Reprod., 17, 284-288.
51. Wenzl, R.J. and Heinzl, H. (1998) Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol. Obstet. Invest., 45, 253-257.
52. Witz, C.A., Thomas, M.R., Montoya-Rodriguez, I.A., Nair, A.S., Centonze, V.E. and Schenken, R.S. (2001) Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil. Steril., 75, 385-390.